35
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Comparative Analysis of Cytokines Released by Bone Marrow Stromal Cells from Normal Donors and B-cell Chronic Lymphocytic Leukemic Patients

, , , &
Pages 127-133 | Published online: 01 Jul 2009

References

  • Greenberger J. The hematopoietic microenvironment. Crit. Rev. Oncol. Hematol 1991; 11: 65–84
  • Dorshkind K. Regulation of hemopoiesis by bone marrow stromal cells and their products. Annu. Rev. Immunol. 1990; 8: 111–137
  • Kittler E., McGrath H., Temeles D., Crittenden R., Kay Kister V., Quesenbery P. Biological significance of constitutive and subliminal growth factor production by bone marrow stroma. Blood 1992; 79: 3168–3178
  • Stryckmans P., Vandenplas B., Dorval C., Vandenbussche P., Massy M., Bernier M., Content J. Decreased production of IL-6 by peripheral blood mononuclear cells of patients with chronic lymphocytic leukemia and related disorders. Nouv. Rev. Fr. Hematol. 1988; 30: 321–323
  • Freeman G., Freedman A., Rabinowe S., Segil J., Horowitz J., Rosen K., Whitman J., Nadler L. Interleukin 6 gene expression in normal and neoplastic B cells. J. Clin. Invest. 1989; 83: 1512–1518
  • Aderka D., Maor Y., Novick D., Engelman H., Kahn Y., Levo Y., Wallach D., Revel M. Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-a or (J. Blood 1993; 81: 2076–2084
  • Rozman C., Montserrat E., Rodriguez-Fernandez J.M., Ayats R., Vallespi T., Parody R., Rios A., Prados D., Morey M., Gomis F., Alcata A., Gutierrez M., Maldonado J., Gonzalez C., Giralt M., Hernandez-Nieto L., Cabrena M., Fernandez-Ranada J.M. Bone marrow histologic pattern. The best single prognostic parameter in chronic lymphocytic leukemia. A multivariate analysis of 329 cases. Blood 1984; 64: 642–648
  • Dighiero G., Travade P., Chevret S., Fenaux P., Chastang C., Binet J.L. The French Cooperative Group on CLL, B-Cell chronic lymphocytic leukemia: present status and future directions. Blood 1991; 15: 1901–1914
  • Hirano T., Akira S., Taga T., Kishimoto T. Biological and clinical aspects of interleukin-6. Immunol. Today 1990; 11: 443–449
  • Fibbe W.E., Van Damme J., Billiau A., Goselinck H.M., Voogt P.J., Van Eeden G., Ralph P., Altrack B.W., Falkenburg J. H. F. Interleukin-1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colony-stimulating factor. Blood 1988; 71: 430–435
  • Lagneaux L., Delforge A., Snoeck R., Stryckmans P., Bron D. Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cells. Exp. Hematol. 1994; 22: 26–30
  • Gordon M., Hibbin J., Kearney L., Gordon-Smith E., Goldman J. Colony formation by primitive haemopoietic progenitors in coculture of bone marrow cells and stromal cells. Br. J. Haematol 1985; 60: 129–136
  • Pike B., Robinson W. Human bone marrow colony growth in agar gel. J. Cell. Physiol 1970; 76: 77–84
  • Ikeda T., Lioubin M., Marquardt H. Human transforming growth factor ($2: Production by aprostatic adenocarcinoma cell line, purification, and initial characterization. Biochemistry 1987; 26: 2406–2410
  • Roberts A., Lamb L., Newton D., Sporn M., Delarco J., Todaro G. Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells. Proc. Natl. Acad. Sci. USA 1980; 77: 3494–3498
  • Lagneaux L., Delforge A., Dorval C., Bron D., Stryckmans P. Excessive production of transforming growth factor-fi by bone marrow stromal cells in B-cell chronic lymphocytic leukemia inhibits growth of hematopoietic precursors and interleukin-6 production. Blood 1993; 82: 2379–2385
  • Murphy M., Perussia B., Trinchivu G. Effects of recombinant tumor necrosis factor, lymphotoxin and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells. Exp. Hematol 1988; 16: 131–138
  • Delforge A., Vandenplas B., Lagneaux L., Loos M., Bron D., Debusscher L., Stryckmans P. Influence of recombinant alpha and gamma interferons on the in vitro proliferation of myeloid and leukemic progenitors. Eur. J. Haematol 1990; 44: 307–311
  • Hino M., Tojo A., Miyazono K., Urabe A., Takaku F. Effects of type β transforming growth factors on haematopoietic progenitor cells. Br. J. Haematol 1988; 70: 143–147
  • Musso T., Espinoza-Delgado I., Pulkki K., Gusella G., Longo D., Varesio L. Transforming growth factor p downregulates interleukin-1 (IL-1) induced 1L-6 production by human monocytes. Blood 1990; 76: 2466–2469
  • Ploemacher R.E., Van Soest P.L., Boudewijn A. Autocrine transforming growth factor β1 blocks colony formation and progenitor cell generation by hematopoietic stem cells stimulated with steel factor. Stem Cells 1993; 11: 336–347
  • Bron D., Lagneaux L., Delforge A., Otte C., Snoeck R., Stryckmans P. Prevention of CMV-induced myelosuppres-sion by anti-CMV antibodies: an in vitro model. Exp. Hematol 1991; 19: 132–135
  • Lyons R., Keski-Oja J., Moses H. Proteolytic activation of latent transforming growth factor-beta fibroblast-conditioned medium. J. Cell. Biol 1988; 106: 1659–1665
  • Grotendorst G., Smale G., Pencev D. Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils. J. Cell. Physiol 1989; 140: 396–402
  • De Waal-Malefyt R., Yssel H., Roncarolo M.G., Spits H., De Vries J. Interleukin-10. Cur. Opin. Immunol. 1992; 4: 314–320
  • Rousset F., Garcia E., Defrance F., Péronne C., Vezzio N., Hsu R., Kastelein K., Moore W., Howard M. Interleukin-10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 1990; 89: 1890–1893
  • Lagneaux L., Delforge A., Snoeck R., Schols D., Bosmans E., De Clercq E., Stryckmans P., Bron D. Differential effect of cytomegalovirus (CMV) on G-CSF, GM-CSF, IL-6, IL-10 and TGF-β production by human bone marrow stromal cells. Br. J. Haematol 1994; 87: 100, (abstr)
  • Wetzler M., Kurzrock R., Lowe D., Kantarjian H., Gutterman J., Talpaz M. Alteration in bone marrow adherent layer growth factor expression: a novel mechanism of chronic myelogenous leukemia progression. Blood 1991; 78: 2400–2406
  • Hilton D., Gough N. Leukemia inhibitory factor: a biological perspective. J. Cell. Biochem. 1991; 46: 21–26
  • Wetzler M., Talpaz M., Lowe D., Baiocchi G. Constitutive expression of leukemia inhibitory factor RNA by human bone marrow stromal cells and modulation by IL-1, TNF-α and TGF-β. Exp. Hematol 1991; 19: 347–351
  • Chantry D., Turner M., Abney E., Feldman M. Modulation of cytokine production by transforming growth factor-β. J. Immunol. 1989; 142: 4295–4300
  • Lotz M., Kipps T. Expression of transforming growth factor-P and anergy in chronic lymphocytic leukemia. Blood 1991; 78: 1527, (abstr)
  • O'Connor-McCourt M., Wakefield L. Latent transforming growth factor-p in serum. J. Biol. Chem. 1987; 262: 14090–14099
  • Moore J., Capocasale R., Fox F., Lamb R., Besa E., Penziner A., Nowell P. Response of CLL B cells to transforming growth factor-beta reflects biological heterogeneity. Blood 1993; 82: 2275, (abstr)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.